Andrew Young

Andrew Young

Grundare på
Phoundry Pharmaceuticals, Inc.
73 år
Health Technology
Consumer Services
Government

Profil

Andrew Young is the founder of Satiogen Pharmaceuticals, Inc. (founded in 2007) and Phoundry Pharmaceuticals, Inc. (founded in 2015, where he also holds the title of Director & Chief Scientific Officer).
He previously worked as Vice President-Research at Amylin Pharmaceuticals, Inc., as a Professor-Physiology Department at Auckland University, and as a Clinical Research Scientist at the National Institutes of Health from 1984 to 1987.
Dr. Young received his graduate and doctorate degrees from Auckland University.

Aktiva positioner av Andrew Young

FöretagPositionStart
Grundare 2015-01-01

Tidigare kända positioner av Andrew Young

FöretagPositionSlut
Teknisk/Vetenskaplig/F&U Direktör 1987-01-01
Grundare -
Företagsledare/Principal -
Teknisk/Vetenskaplig/F&U Direktör -
Se detaljerna i Andrew Youngs erfarenhet

Andrew Youngs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

13

Första gradens relationer

5

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag5

Health Technology

Consumer Services

Government

Commercial Services

Health Technology

  1. Börsen
  2. Insiders
  3. Andrew Young